BIODEXA PHARMACEUTICALS-ADR (BDRX) Stock Income Statement
NASDAQ:BDRX - Nasdaq - US59564R8079 - ADR - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 83.00K | 381.00K | 699.00K | 578.00K | 343.00K | |||
| Operating Expenses | 8.08M | 8.39M | 9.63M | 7.58M | 11.01M | |||
| Research and Development | 4.00M | 4.07M | 5.11M | 4.65M | 6.07M | |||
| Selling, General, and Administrative Expenses | 4.08M | 4.34M | 4.54M | 2.95M | 4.96M | |||
| Operating Income | -7.99M | -8.01M | -8.93M | -7.00M | -10.67M | |||
| Interest Income/Expense | 957.00K | 519.00K | 444.00K | 892.00K | -430.00K | |||
| Other Income/Expense | -26.00K | 10.00K | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | 0.00 | 0.00 | -12.37M | |||
| Income Before Taxes | -7.06M | -7.49M | -8.49M | -6.11M | -23.47M | |||
| Income Tax | -243.00K | -406.00K | -832.00K | -646.00K | -1.28M | |||
| Net Income | -6.82M | -7.08M | -7.66M | -5.46M | -22.19M | |||
| EBITDA | -7.72M | -7.73M | -8.59M | -6.59M | -9.45M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -59.52 | -109.97 | -30.41K | -13.33M | -4.07M | |||
| Statistics | ||||||||
| Profit Margin | -8215.66% | -1858.01% | -1095.28% | -944.64% | -6469.10% | |||
| Operating Profit Margin | -9630.12% | -2103.41% | -1277.83% | -1210.73% | -3111.08% | |||
All data in GBP